Diagnostic value of serum brain natriuretic peptide in chronic renal failure patients with chronic heart failure
10.3760/cma.j.issn.1008-6706.2010.08.009
- VernacularTitle:脑钠肽对慢性肾衰竭合并心力衰竭的诊断价值
- Author:
Aiguo ZHAO
;
Xiaoyun GUO
;
Tian XIA
;
Rusong SU
- Publication Type:Journal Article
- Keywords:
Natriuretic peptide,Brain;
Heart failure,Congestive;
Kidney failure
- From:
Chinese Journal of Primary Medicine and Pharmacy
2010;17(8):1026-1028,后插2
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the influence of renal function on serum BNP in the diagnosis of CRF with heart failure by observing the relationship between eGFR and BNP in serum and comparing cut-off values of BNP in different eGFR levels. Methods The elderly participants were enrolled in the study, including 52 patients with heart failure, and 29 patients without heart failure and 30 healthy controls. Serum BNP level was measured by ELISA.Results The level of serum BNP increased significantly in subjects with heart failure compared with those with renal dysfunction for no-heart failure patients (P ＜ 0.05) and healthy controls. BNP level was significantly higher in CRF no-heart failure patients than in control subjects. eGFR showed negative correlation with BNP in ESRD no-heart failure patients (γ= -0. 581, P ＜ 0.01). There was no correlation between eGFR and ESRD with heart failure patients (γ= - 0.081, P ＞ 0.05). The AUC of BNP in patients (eGFR 30 ～ 60 ml) was 0. 951, when cut-off value was 1 500 ng/L,the sensitivity and specificity of BNP were 96.4% and 86. 7% respectively. The AUC of BNP in patients(eGFR ＜30 ml)was 0. 860, when cut-off value was 1 850 ng/L,the sensitivity and specificity of B NP were 66.7% and 92.9%respectively. Conclusions Heart failure was major factor result in higher levels of BNP in chronic renal failure with heart failure patients. BNP could be used as a diagnostic marker for CRF with heart failure patients.
